DENVER, Oct. 19, 2006 (PRIMEZONE) -- The law firm of Shuman & Berens LLP (www.shumanberens.com) today encouraged persons who currently own the common stock of Valeant Pharmaceuticals International (NYSE:VRX) to contact Kip B. Shuman of Shuman & Berens LLP at 1-800-711-6483 or via email at Kip@shumanberens.com, concerning their rights and interests regarding possible stock option backdating at the company.
Shuman & Berens LLP is investigating the possible backdating of Valeant Pharmaceuticals stock options granted to company employees. On September 11, 2006 the company announced that the SEC is investigating its historical stock option grants.
For a free consultation regarding your rights and interests with respect to your Valeant Pharmaceuticals stockholdings, you may contact Kip B. Shuman of Shuman & Berens LLP at 1-800-711-6483, or via email at Kip@shumanberens.com
Shuman & Berens LLP attorneys have extensive experience in prosecuting shareholder litigation and have played significant roles in securities actions throughout the nation, resulting in substantial recoveries to investors. For more information about Shuman & Berens LLP go to (www.shumanberens.com).